[1]Gadgeel SM.Personalized therapy of non-small cell lung cancer(NSCLC)[J].Adv Exp Med Biol,2016,890:203-222.
[2]Amendola BE,Amendola MA,Perez N,et al.Local failure after primary radiotherapy in lung cancer:Is there a role for SBRT[J]?Rep Pract Oncol Radiother,2015,20(6):440-445.
[3]Alharbi KK,Ali Khan I,Syed R,et al.Association of JAZF1 and TSPAN8/LGR5 variants in relation to type 2 diabetes mellitus in a Saudi population[J].Diabetol Metab Syndr,2015,7:92.
[4]Nazarenko I,Rana S,Baumann A,et al.Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation[J].Cancer Res,2010,70(4):1668-1678.
[5]Yue S,Mu W,Zoller M.TSPAN8 and CD151 promote metastasis by distinct mechanisms[J].Eur J Cancer,2013,49(13):2934-2948.
[6]Wei L,Li Y,Suo Z.TSPAN8 promotes gastric cancer growth and metastasis via ERK MAPK pathway[J].Int J Clin Exp Med,2015,8(6):8599-8607.
[7]Berthier-Vergnes O,Kharbili ME,De la Fouchardière A,et al.Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion[J].Br J Cancer,2011,104(1):155-165.
[8]Pan SJ,Wu YB,Cai S,et al.Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression[J].Biochem Biophys Res Commun,2015,458(3):476-482.
[9]Roberts E,Cossigny DA,Quan GM.The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton[J].Prostate Cancer,2013,2013:418340.
[10]Anami K,Oue N,Noguchi T,et al.TSPAN8,identified by Escherichia coli ampicillin secretion trap,is associated with cell growth and invasion in gastric cancer[J].Gastric Cancer,2016,19(2):370-380.
[11]Fang TT,Sun XJ,Chen J,et al.Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential[J].Asian Pac J Cancer Prev,2014,15(23):10513-10524.
[12]Greco C,Bralet MP,Ailane N,et al.E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell motility control in human colon carcinoma[J].Cancer Res,2010,70(19):7674-7683.
[13]Ahn SM,Jang SJ,Shim JH,et al.Genomic portrait of resectable hepatocellular carcinomas:Implications of RB1 and FGF19 aberrations for patient stratification[J].Hepatology,2014,60(6):1972-1982.
[14]Dumanskiy YV,Stoliarova OY,Syniachenko OV,et al.Endothelial dysfunction of vessels at lung cancer[J].Exp Oncol,2015,37(4):277-280.
[15]Li X,Yang L,Shuai T,et al.MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression[J].Biomed Pharmacother,2016,82:247-255.
[16]Liao X,Zhou X,Mak NK,et al.Tryptanthrin inhibits angiogenesis by targeting the VEGFR2-mediated ERK1/2 signalling pathway[J].PLoS One,2013,8(12):e82294.